NYU Langone Health in the News—October 16, 2025
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from October 16, 2025.
NYU Langone Performs First Successful Face & Hand Transplant
An NYU Langone team performs the world’s first successful face and double hand transplant for a 22-year-old New Jersey resident.
Perlmutter Cancer Center Hosts Immunotherapy Patient Summit
Experts from NYU Langone’s Perlmutter Cancer Center informed cancer patients, caregivers, and advocates of new breakthroughs in immunotherapy.
POCUS CME Course Flyer
... the QR code or click here. Continuing Medical Education ...
Redefining Quality Stroke Care, Protocol by Protocol
Clinicians at NYU Langone’s Center for Stroke and Neurovascular Diseases build processes and protocols aimed at delivering quality stroke care.
Study Links Pharma Marketing to Opioid Deaths
A new study led by NYU School of Medicine shows a correlation between pharma marketing targeted to physicians and increased opioid deaths.
Suppressing the Spread of Melanoma
NYU Langone scientists have found two cell-signaling molecules, called microRNAs, which suppress the spread of melanoma.
The Flu Shot Doesn’t Give You the Flu
NYU Langone pediatrician Dr. Robin S. Jacobson speaks with Good Housekeeping to bust the myth that the flu shot makes you sick.
What Do Sleep Terrors in Children Look Like?
Dr. Sara Siddiqui, pediatrician at Hassenfeld Children’s Hospital at NYU Langone, discusses sleep terrors and how to help a child who’s having one.
Why Treating KRAS-Mutant Lung Cancers Is Challenging
Researchers at NYU Langone’s Perlmutter Cancer Center discuss why KRAS-mutant lung cancers are difficult to treat.